Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT04954820
Title Assessment of the Schema of Retreatment With Lutathera® in Patients With New Progression of Intestinal Well-differenciated Neuroendocrine Tumor (ReLUTH)
Acronym ReLUTH
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Institut du Cancer de Montpellier - Val d'Aurelle
Age Groups: senior | adult
Covered Countries FRA

No variant requirements are available.